1-3 of 3
Cornelis J. A. Punt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

Erik H. J. G. Aarntzen, Gerty Schreibelt, Kalijn Bol, W. Joost Lesterhuis, Alexandra J. Croockewit, Johannes H. W. de Wilt, Michelle M. van Rossum, Willeke A. M. Blokx, Joannes F. M. Jacobs, Tjitske Duiveman-de Boer, Danita H. Schuurhuis, Roel Mus, Kris Thielemans, I. Jolanda M. de Vries, Carl G. Figdor, Cornelis J. A. Punt, Gosse J. Adema
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5460–5470.
https://doi.org/10.1158/1078-0432.CCR-11-3368
Published: 30 September 2012
View article titled, Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cells Responses in Stage III and IV Melanoma Patients
Open the PDF for Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4<sup>+</sup> and CD8<sup>+</sup> T Cells Responses in Stage III and IV Melanoma Patients in another window
Includes: Supplementary data
Journal Articles

Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients

I. Jolanda M. de Vries, W. Joost Lesterhuis, Nicole M. Scharenborg, Linda P. H. Engelen, Dirk J. Ruiter, Marie-Jeanne P. Gerritsen, Sandra Croockewit, Cedrik M. Britten, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor, Cornelis J. A. Punt
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5091–5100.
Published: 12 November 2003
View article titled, Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
Open the PDF for Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients in another window
Journal Articles

A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors

Giuseppe Giaccone, Cornelis J. A. Punt, Yoshitaka Ando, Rita Ruijter, Nobusuke Nishi, Marlies Peters, B. Mary E. von Blomberg, Rik J. Scheper, Hans J. J. van der Vliet, Alfons J. M. van den Eertwegh, Marja Roelvink, Jos Beijnen, Heinz Zwierzina, Herbert M. Pinedo
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3702–3709.
Published: 01 December 2002
View article titled, A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors
Open the PDF for A Phase I Study of the Natural Killer T-Cell Ligand α-Galactosylceramide (KRN7000) in Patients with Solid Tumors in another window